Abstract
The management of early T-stage oropharyngeal cancer remains a controversial topic with an absence of high-level evidence supporting one treatment approach over another. The current status of best evidence demonstrates oncologic equivalency of these treatment modalities. The choice between surgical and non-surgical management of early stage OPSCC is therefore quite nuanced and is driven by patient selection, functional outcomes, cost-effectiveness, and patient preference. Transoral surgery alone in the appropriately selected patient has improved overall functional results as compared with definitive radiotherapy, however when adjuvant (chemo)radiotherapy is needed functional outcomes are worse and do not appear better than definitive radiotherapy alone. There are currently many ongoing de-intensification trials which will further inform which patients will benefit the most from a functional standpoint while preserving excellent oncologic outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
National Comprehensive Cancer Network (NCCN). Head and neck cancer. http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf. Published 2014. Accessed 12 Jan 2015.
Mourad M, Jetmore T, Jategaonkar AA, Moubayed S, Moshier E, Urken ML. Epidemiological trends of head and neck cancer in the United States: a SEER population study. J Oral Maxillofac Surg. 2017;75(12):2562–72.
Weatherspoon DJ, Chattopadhyay A, Boroumand S, Garcia I. Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000–2010. Cancer Epidemiol. 2015;39(4):497–504.
Megwalu UC, Sirjani D, Devine EE. Oropharyngeal squamous cell carcinoma incidence and mortality trends in the United States, 1973–2013. Laryngoscope. 2018;128(7):1582–8.
Petrelli F, Sarti E, Barni S. Predictive value of human papillomavirus in oropharyngeal carcinoma treated with radiotherapy: an updated systematic review and meta-analysis of 30 trials. Head Neck. 2014;36(5):750–9.
Wang MB, Liu IY, Gornbein JA, Nguyen CT. HPV-positive oropharyngeal carcinoma: a systematic review of treatment and prognosis. Otolaryngol Head Neck Surg. 2015;153(5):758–69.
Members NP. NCCN Clinical Practice Guidelines in Oncology: head and neck cancer. http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf. Published 2017. Accessed 28 Aug 2017.
Lydiatt WM, Patel SG, O’Sullivan B, et al. Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):122–37.
Howard J, Masterson L, Dwivedi RC, et al. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma. Cochrane Database Syst Rev. 2016;12:CD010963.
Rubek N, Channir HI, Charabi BW, et al. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status. Eur Arch Otorhinolaryngol. 2017;274(5):2229–37.
Cracchiolo JR, Baxi SS, Morris LG, et al. Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base. Cancer. 2016;122(10):1523–32.
de Almeida JR, Byrd JK, Wu R, et al. A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: a systematic review. Laryngoscope. 2014;124(9):2096–102.
Kelly K, Johnson-Obaseki S, Lumingu J, Corsten M. Oncologic, functional and surgical outcomes of primary Transoral Robotic Surgery for early squamous cell cancer of the oropharynx: a systematic review. Oral Oncol. 2014;50(8):696–703.
Morisod B, Simon C. Meta-analysis on survival of patients treated with transoral surgery versus radiotherapy for early-stage squamous cell carcinoma of the oropharynx. Head Neck. 2016;38(Suppl 1):E2143–50.
O’Rorke MA, Ellison MV, Murray LJ, Moran M, James J, Anderson LA. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol. 2012;48(12):1191–201.
Garden AS, Morrison WH, Wong PF, et al. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2007;67(2):438–44.
Eisbruch A, Harris J, Garden AS, et al. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys. 2010;76(5):1333–8.
Cosmidis A, Rame JP, Dassonville O, et al. T1–T2 NO oropharyngeal cancers treated with surgery alone. A GETTEC study. Eur Arch Otorhinolaryngol. 2004;261(5):276–81.
Dabas S, Gupta K, Ranjan R, Sharma AK, Shukla H, Dinesh A. Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): a prospective trial. Oral Oncol. 2017;69:80–3.
Moore EJ, Ebrahimi A, Price DL, Olsen KD. Retropharyngeal lymph node dissection in oropharyngeal cancer treated with transoral robotic surgery. Laryngoscope. 2013;123(7):1676–81.
Chung EJ, Kim GW, Cho BK, Cho SJ, Yoon DY, Rho YS. Retropharyngeal lymph node metastasis in 54 patients with oropharyngeal squamous cell carcinoma who underwent surgery-based treatment. Ann Surg Oncol. 2015;22(9):3049–54.
Troob S, Givi B, Hodgson M, et al. Transoral robotic retropharyngeal node dissection in oropharyngeal squamous cell carcinoma: patterns of metastasis and functional outcomes. Head Neck. 2017;39(10):1969–75.
Selek U, Garden AS, Morrison WH, El-Naggar AK, Rosenthal DI, Ang KK. Radiation therapy for early-stage carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys. 2004;59(3):743–51.
Jayaram SC, Muzaffar SJ, Ahmed I, Dhanda J, Paleri V, Mehanna H. Efficacy, outcomes, and complication rates of different surgical and nonsurgical treatment modalities for recurrent/residual oropharyngeal carcinoma: a systematic review and meta-analysis. Head Neck. 2016;38(12):1855–61.
Routman DM, Funk RK, Tangsriwong K, et al. Relapse rates with surgery alone in human papillomavirus-related intermediate- and high-risk group oropharynx squamous cell cancer: a multi-institutional review. Int J Radiat Oncol Biol Phys. 2017;99(4):938–46.
Sims JR, Van Abel K, Martin EJ, et al. Management of recurrent and metastatic HPV-positive oropharyngeal squamous cell carcinoma after transoral robotic surgery. Otolaryngol Head Neck Surg. 2017;157(1):69–76.
Janot F, de Raucourt D, Benhamou E, et al. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol. 2008;26(34):5518–23.
Dawe N, Patterson J, O’Hara J. Functional swallowing outcomes following treatment for oropharyngeal carcinoma: a systematic review of the evidence comparing trans-oral surgery versus non-surgical management. Clin Otolaryngol. 2016;41(4):371–85.
Dziegielewski PT, Teknos TN, Durmus K, et al. Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes. JAMA Otolaryngol Head Neck Surg. 2013;139(11):1099–108.
Ryzek DF, Mantsopoulos K, Künzel J, et al. Early stage oropharyngeal carcinomas: comparing quality of life for different treatment modalities. Biomed Res Int. 2014;2014:421964.
Choby GW, Kim J, Ling DC, et al. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes. JAMA Otolaryngol Head Neck Surg. 2015;141(6):499–504.
van Loon JW, Smeele LE, Hilgers FJ, van den Brekel MW. Outcome of transoral robotic surgery for stage I–II oropharyngeal cancer. Eur Arch Otorhinolaryngol. 2015;272(1):175–83.
Ling DC, Chapman BV, Kim J, et al. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation. Oral Oncol. 2016;61:41–6.
Achim V, Bolognone RK, Palmer AD, et al. Long-term functional and quality-of-life outcomes after transoral robotic surgery in patients with oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2017. https://doi.org/10.1001/jamaoto.2017.1790.
Sethia R, Yumusakhuylu AC, Ozbay I, et al. Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer. Laryngoscope. 2018;128(2):403–11.
Chen AM, Daly ME, Luu Q, Donald PJ, Farwell DG. Comparison of functional outcomes and quality of life between transoral surgery and definitive chemoradiotherapy for oropharyngeal cancer. Head Neck. 2015;37(3):381–5.
de Almeida JR, Park RC, Villanueva NL, Miles BA, Teng MS, Genden EM. Reconstructive algorithm and classification system for transoral oropharyngeal defects. Head Neck. 2014;36(7):934–41.
Setton J, Lee NY, Riaz N, et al. A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy. Cancer. 2015;121(2):294–301.
Goepfert RP, Lewin JS, Barrow MP, et al. Long-term, prospective performance of the MD Anderson Dysphagia Inventory in “low-intermediate risk” oropharyngeal carcinoma after intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2017;97(4):700–8.
Hutcheson KA, Holsinger FC, Kupferman ME, Lewin JS. Functional outcomes after TORS for oropharyngeal cancer: a systematic review. Eur Arch Otorhinolaryngol. 2015;272(2):463–71.
Genden EM, Kotz T, Tong CC, et al. Transoral robotic resection and reconstruction for head and neck cancer. Laryngoscope. 2011;121(8):1668–74.
More YI, Tsue TT, Girod DA, et al. Functional swallowing outcomes following transoral robotic surgery vs primary chemoradiotherapy in patients with advanced-stage oropharynx and supraglottis cancers. JAMA Otolaryngol Head Neck Surg. 2013;139(1):43–8.
O’Hara J, Goff D, Cocks H, et al. One-year swallowing outcomes following transoral laser microsurgery +/− adjuvant therapy versus primary chemoradiotherapy for advanced stage oropharyngeal squamous cell carcinoma. Clin Otolaryngol. 2016;41(2):169–75.
Sharma A, Patel S, Baik FM, et al. Survival and gastrostomy prevalence in patients with oropharyngeal cancer treated with transoral robotic surgery vs chemoradiotherapy. JAMA Otolaryngol Head Neck Surg. 2016;142(7):691–7.
Zenga J, Suko J, Kallogjeri D, Pipkorn P, Nussenbaum B, Jackson RS. Postoperative hemorrhage and hospital revisit after transoral robotic surgery. Laryngoscope. 2017;127(10):2287–92.
Pollei TR, Hinni ML, Moore EJ, et al. Analysis of postoperative bleeding and risk factors in transoral surgery of the oropharynx. JAMA Otolaryngol Head Neck Surg. 2013;139(11):1212–8.
Kubik M, Mandal R, Albergotti W, Duvvuri U, Ferris RL, Kim S. Effect of transcervical arterial ligation on the severity of postoperative hemorrhage after transoral robotic surgery. Head Neck. 2017;39(8):1510–5.
Asher SA, White HN, Kejner AE, Rosenthal EL, Carroll WR, Magnuson JS. Hemorrhage after transoral robotic-assisted surgery. Otolaryngol Head Neck Surg. 2013;149(1):112–7.
Zenga J, Graboyes EM, Sinha P, Haughey BH. The unplanned intraoperative pharyngotomy: pull, plug, or patch. Laryngoscope. 2015;125(12):2736–40.
Kerawala CJ, Heliotos M. Prevention of complications in neck dissection. Head Neck Oncol. 2009;1:35.
Pollard JM, Gatti RA. Clinical radiation sensitivity with DNA repair disorders: an overview. Int J Radiat Oncol Biol Phys. 2009;74(5):1323–31.
De Naeyer B, De Meerleer G, Braems S, Vakaet L, Huys J. Collagen vascular diseases and radiation therapy: a critical review. Int J Radiat Oncol Biol Phys. 1999;44(5):975–80.
Hawkins PG, Kadam AS, Jackson WC, Eisbruch A. Organ-sparing in radiotherapy for head-and-neck cancer: improving quality of life. Semin Radiat Oncol. 2018;28(1):46–52.
De Felice F, Musio D, Tombolini V. Osteoradionecrosis and intensity modulated radiation therapy: an overview. Crit Rev Oncol Hematol. 2016;107:39–43.
Caparrotti F, Huang SH, Lu L, et al. Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy. Cancer. 2017;123(19):3691–700.
Hutcheson KA, Yuk M, Hubbard R, et al. Delayed lower cranial neuropathy after oropharyngeal intensity-modulated radiotherapy: a cohort analysis and literature review. Head Neck. 2017;39(8):1516–23.
Rodin D, Caulley L, Burger E, et al. Cost-effectiveness analysis of radiation therapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2017;97(4):709–17.
Sher DJ, Fidler MJ, Tishler RB, Stenson K, al-Khudari S. Cost-effectiveness analysis of chemoradiation therapy versus transoral robotic surgery for human papillomavirus-associated, clinical N2 oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2016;94(3):512–22.
de Almeida JR, Moskowitz AJ, Miles BA, et al. Cost-effectiveness of transoral robotic surgery versus (chemo)radiotherapy for early T classification oropharyngeal carcinoma: a cost-utility analysis. Head Neck. 2016;38(4):589–600.
Rudmik L, An W, Livingstone D, et al. Making a case for high-volume robotic surgery centers: a cost-effectiveness analysis of transoral robotic surgery. J Surg Oncol. 2015;112(2):155–63.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Zenga, J., Richmon, J.D. (2019). Surgical Versus Non-surgical Management of Early T-Stage Oropharyngeal Cancer. In: Gooi, Z., Agrawal, N. (eds) Difficult Decisions in Head and Neck Oncologic Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-030-15123-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-15123-2_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-15122-5
Online ISBN: 978-3-030-15123-2
eBook Packages: MedicineMedicine (R0)